Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$47.5M |
| 2 |
Johnson & Johnson
JNJ
|
+$34.9M |
| 3 |
Phillips 66
PSX
|
+$34.7M |
| 4 |
Chevron
CVX
|
+$31.9M |
| 5 |
Johnson Controls International
JCI
|
+$31.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COUP
Coupa Software Incorporated
COUP
|
+$51.8M |
| 2 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$49.5M |
| 3 |
EVOP
EVO Payments, Inc. Class A Common Stock
EVOP
|
+$48.2M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$37.7M |
| 5 |
STOR
STORE Capital Corporation
STOR
|
+$23.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.69% |
| 2 | Industrials | 11.81% |
| 3 | Healthcare | 11.19% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVRI
1926
DELISTED
Everi Holdings
EVRI
| $302K | ﹤0.01% |
17,615
-189,925
| -92% | -$3.28M |
|
1927
HCI Group
HCI
$2.31B
| $302K | ﹤0.01% |
5,640
-6,680
| -54% | -$336K |
|
|
NOVA
1928
DELISTED
Sunnova Energy
NOVA
| $302K | ﹤0.01% |
19,312
-7,142
| -27% | -$125K |
|
1929
PUT
TE Connectivity
TEL
$58.6B
| $302K | ﹤0.01% |
+2,300
| New | +$291K |
|
1930
CALL
Omega Healthcare
OHI
$14.1B
| $301K | ﹤0.01% |
+10,900
| New | +$303K |
|
1931
CALL
Lemonade
LMND
$4.17B
| $300K | ﹤0.01% |
20,900
-2,400
| -10% | -$36.5K |
|
|
NTST
1932
NETSTREIT Corp
NTST
$2.11B
| $300K | ﹤0.01% |
16,409
-45,482
| -73% | -$878K |
|
1933
CALL
Quanta Services
PWR
$92.7B
| $300K | ﹤0.01% |
+1,800
| New | +$277K |
|
1934
Wingstop
WING
$3.18B
| $300K | ﹤0.01% |
1,636
-7,893
| -83% | -$1.3M |
|
1935
Fate Therapeutics
FATE
$292M
| $299K | ﹤0.01% |
52,434
-350
| -0.7% | -$2.11K |
|
1936
PUT
Autoliv
ALV
$9.02B
| $298K | ﹤0.01% |
+3,200
| New | +$282K |
|
1937
CALL
Cooper Companies
COO
$14.8B
| $298K | ﹤0.01% |
+3,200
| New | +$275K |
|
|
1938
PUT
Cooper Companies
COO
$14.8B
| $298K | ﹤0.01% |
+3,200
| New | +$275K |
|
|
SCHW
1939
CALL
Charles Schwab
SCHW
$197B
| $298K | ﹤0.01% |
5,700
+500
| +10% | +$36.6K |
|
1940
State Street SPDR Dow Jones International Real Estate ETF
RWX
$267M
| $296K | ﹤0.01% |
11,276
+3,588
| +47% | +$97.9K |
|
1941
PUT
State Street
STT
$52.4B
| $296K | ﹤0.01% |
3,900
-29,000
| -88% | -$2.44M |
|
|
TPIC
1942
DELISTED
TPI Composites
TPIC
| $296K | ﹤0.01% |
22,693
-55,297
| -71% | -$705K |
|
1943
PUT
APA Corp
APA
$15.1B
| $295K | ﹤0.01% |
+8,200
| New | +$329K |
|
|
NFBK
1944
DELISTED
Northfield Bancorp
NFBK
| $295K | ﹤0.01% |
25,056
-41,474
| -62% | -$593K |
|
1945
PUT
Asbury Automotive
ABG
$3.79B
| $294K | ﹤0.01% |
1,400
+200
| +17% | +$42.4K |
|
1946
CALL
Nexstar Media Group
NXST
$5.74B
| $294K | ﹤0.01% |
+1,700
| New | +$313K |
|
1947
CALL
Valero Energy
VLO
$99.6B
| $294K | ﹤0.01% |
2,100
-6,800
| -76% | -$914K |
|
1948
PUT
Essex Property Trust
ESS
$18.9B
| $293K | ﹤0.01% |
1,400
-1,400
| -50% | -$309K |
|
1949
Revolution Medicines
RVMD
$45.3B
| $293K | ﹤0.01% |
13,514
+4,075
| +43% | +$100K |
|
1950
CALL
Church & Dwight Co
CHD
$24.3B
| $292K | ﹤0.01% |
+3,300
| New | +$275K |
|
Similar funds
Paul Tudor Jones's Q1 2023 Portfolio in Review
As of Q1 2023, Paul Tudor Jones held 3,136 positions worth $6.46B, up 28% from $5.06B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
Paul Tudor Jones deployed $1.28B of net new capital in Q1 2023, opening 836 new positions and adding to 737 existing holdings. Its largest new stake was Johnson & Johnson: 216,183 shares worth $33.5M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $37.7M trimmed.
- Paul Tudor Jones's largest Q1 2023 buy was Johnson & Johnson: 216,183 shares worth $33.5M.
- Paul Tudor Jones added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $47.5M increase.
- Paul Tudor Jones's biggest Q1 2023 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $37.7M.
- Paul Tudor Jones fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $51.8M.
- Paul Tudor Jones's ten largest holdings make up 6.8% of its $6.46B portfolio in Q1 2023.
- Paul Tudor Jones opened 836 new positions and closed 800 in Q1 2023.
- Paul Tudor Jones's portfolio value rose 28% quarter-over-quarter to $6.46B.
Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.